Discussion - COMPASS CHF

28 May 2018 (17:10 - 17:15)

Organised by:

Video

Sign in for access options

11 More presentations in this session

Presentation thumbnail

Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction: findings from the CHAMP-HF registry

Doctor Y. Khariton (Kansas City, US)

Presentation thumbnail

Discussion - Sacubitril/Valsartan initiation and health status outcomes in HFrEF

Presentation thumbnail

Subtle ventricular dysfunction outperforms other risk markers in patients with coronary artery disease

Professor D. Kotecha (Birmingham, GB)

Presentation thumbnail

Discussion - ARM-CAD

Presentation thumbnail

Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial

Professor K. Branch (Seattle, US)

Access the full session

Session thumbnail

Late breaking trial IV - Registries

The Event

Heart Failure 2018

28 May 2018 17:10 CET

You may be interested in

Congress Session

Treatment of cardiovascular comorbidities in patients with heart failure

17 May 2025

Congress Presentation

Refinement of a multicomponent nurse intervention for multidisciplinary care in Heart Failure: results from a formal consensus development technique study

13 June 2025

Congress Presentation

Multi-modality imaging in so-called left ventricular non-compaction is critical for diagnosis, risk stratification and patient management - discussion.

9 December 2022

Congress Session

Debate on primary prevention in ICD therapy

30 March 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources